 IMC subsidiary, Adjupharm, to expand German product portfolio with unique strains via supply agreements with The Green Organic Dutchman and Natural MedCo German Brand Institute awards IMC with the German Brand Award 2021 for the Companys successful market launch campaign Israeli Ministerial Committee on Legislative Affairs approves bill for legalization of CBD and decriminalization of cannabis consumers on July 11th TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL ACCESSWIRE July 13, 2021 IM Cannabis Corp. IMC or the Company CSE:IMCC NASDAQ:IMCC, a multi-country operator MCO in the medical and adult-use recreational cannabis sector with operations in Israel, Germany and Canada, is pleased to provide a business, legal and regulatory update on its operations in Germany and Israel. Update on Operations in Germany The Companys EU GMP-certified German subsidiary, Adjupharm GmbH Adjupharm, has entered into two new medical cannabis supply agreements that will broaden its product portfolio and provide a greater base from which to distribute medical cannabis across the EU. 